The pneumococcal vaccine prevents serious blood, brain, and lung infections due to the Streptococcus pneumoniae bacteria. Such infections are called pneumococcal disease -- they also include pneumonia, meningitis, and septicemia.
Pneumococcal disease is a serious health threat that can lead to death. Many strains of Streptococcus pneumonia are resistant to currently used antibiotics. Infection with the bacteria is a leading cause of serious illness in adults and children worldwide. In the U.S. alone, more people die from pneumococcal disease each year than all other vaccine-preventable diseases combined.
Did You Know?
Under the Affordable Care Act, many health insurance plans will cover preventive care services, including checkups, vaccinations and screening tests, at no cost to you. Learn more.
Vaccination is the best way to prevent pneumococcal disease. There are two different types of pneumococcal vaccine. One that protects adults against 23 strains of Streptococcus pneumonia bacteria is called pneumococcal polysaccharide vaccine (PPSV23), and it is marketed under the brand name Pneumovax. PPSV23 is made using dead bacteria. The dead germs cannot make you sick.
PPSV23 is not the same as the other pneumococcal conjugate vaccine, PCV13 (brand name Prevnar 13), which is routinely given to infants and toddlers, but was approved by the FDA in 2011 for use in adults age 50 and older.
When Should Adults Get a Pneumococcal Vaccine?
The pneumococcal vaccine can be given at any time of the year. The pneumococcal polysaccharide vaccine (PPSV23) is recommended for the following adults:
Adults age 19 to 64 years old with certain medical conditions (for example, certain kidney diseases, cigarette smoking, asthma, chronic heart or lung disease, asplenia, and conditions that cause weakening of the immune system) should receive one or two doses of PPSV23 given five years apart.
All adults age 65 years and older who do not have a contraindication, as long as it has been five years since any previous dose of PPSV23.
The pneumococcal conjugate vaccine (PCV13) is recommended for the following adults:
Adults aged 19 years and older with asplenia, sickle cell disease, cerebrospinal fluid leaks, cochlear implants, or conditions that cause weakening of thee immune system.
Adults who are recommended to get both the PPSV23 and the PCV13 vaccines should get the PCV13 vaccine first, followed by PPSV23 eight weeks later. If an adult was already vaccinated with PPSV23, he or she should receive the PCV13 vaccine one year or more later.
Who Needs a Booster Shot of the Pneumococcal Vaccine?
Some people may need a booster shot after five years. The doctor will recommend a second dose of PPSV23 if you are an adult between ages 19 and 64 who has:
A damaged spleen or no spleen
Kidney disease called nephritic syndrome
A weakened immune system due to medications such as chemotherapy drugs and long-term steroids
Cancer, including leukemia, lymphoma, and multiple myeloma
History of an organ or bone marrow transplant
Sickle cell disease
Adults over age 65 who received PPSV23 before age 65 also need a booster shot if it has been more than five years since being vaccinated.